Description for 5-Amino-1MQ 10mg.

The Hidden Fat-Burning Switch: How a Small Molecule Could Flip Metabolism into High Gear in Research Models

What if a tiny, selective inhibitor could silence an enzyme that's quietly sabotaging NAD+ levels, slowing fat oxidation, and locking away energy in white adipose tissue—potentially allowing cells to burn stored fat more efficiently, restore youthful metabolic flexibility, and protect against diet-induced obesity in laboratory models? This is the intriguing possibility driving growing interest in 5-Amino-1MQ 10mg Peptide, a small-molecule research compound studied as a potent inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme implicated in age- and obesity-related metabolic inefficiency.

At Cali BioLab Peptides, we offer 5-Amino-1MQ 10mg Peptide as a high-purity (≥99%), sterile lyophilized powder in a 10mg vial—third-party HPLC/MS verified, batch-specific COAs provided, and shipped fast within the USA. This research-grade compound empowers qualified investigators to explore NNMT inhibition, NAD+ preservation, fat oxidation pathways, and metabolic reprogramming in controlled in-vitro, ex-vivo, or approved animal model studies.

Strict Disclaimer: For laboratory and scientific research use only. Not for human consumption, therapeutic, diagnostic, veterinary, or any non-research application. Strictly intended for qualified researchers conducting in-vitro, ex-vivo, or ethically approved animal model studies. Cali BioLab Peptides maintains full regulatory compliance.

The Obesity Reversal Experiment: Dr. Neha’s High-Fat Diet Mouse Model That Changed the Game

In a metabolic disease research group at a major U.S. university, Dr. Neha Patel was modeling diet-induced obesity (DIO) in C57BL/6 mice fed a 60% high-fat diet for 12 weeks. Her animals developed severe insulin resistance, massive white adipose tissue expansion, reduced energy expenditure, elevated NNMT expression in fat and liver, depleted NAD+ levels, and stalled weight loss despite caloric restriction attempts.

Precursor-based NAD+ boosters (NMN, NR) helped modestly but couldn't overcome the NNMT-driven "methyl sink" that consumed nicotinamide and impaired fat oxidation. Neha sourced 5-Amino-1MQ 10mg Peptide from Cali BioLab Peptides after reviewing key 2018 studies on NNMT inhibitors. The 10mg vial arrived lyophilized with a COA confirming 99.4% purity.

In her 8-week intervention, Neha administered oral or intraperitoneal 5-Amino-1MQ 10mg Peptide (scaled ~10-30 mg/kg/day). The results were striking: treated DIO mice showed significant NNMT inhibition in adipose and liver, restored NAD+ levels, increased oxygen consumption and fat oxidation (indirect calorimetry), reduced white adipose mass (DEXA/MRI), improved insulin sensitivity (lower HOMA-IR), and accelerated body weight loss—even on the high-fat diet—without muscle wasting or overt toxicity.

Neha’s publication in a high-impact metabolism journal demonstrated that 5-Amino-1MQ 10mg Peptide could reverse DIO-induced metabolic dysfunction by breaking the NNMT-NAD+ vicious cycle, earning her team expanded funding and collaborations with NAD+ therapeutics companies. The compound became essential for her group’s obesity reversal and metabolic reprogramming studies.

What Exactly Is 5-Amino-1MQ 10mg Peptide?

5-Amino-1MQ 10mg Peptide (also written as 5-Amino-1-methylquinolinium or 5-Amino-1MQ) is a small-molecule research compound functioning as a selective, cell-permeable inhibitor of nicotinamide N-methyltransferase (NNMT).

Key product specifications:

• Quantity: 10mg sterile lyophilized powder per vial—ideal for dose-response curves, chronic administration in small cohorts, or multiple cell/animal replicates
• Purity: ≥99% (third-party verified by HPLC and Mass Spectrometry)
• Molecular Formula: C₁₀H₁₁N₂⁺ (cationic form)
• Molecular Weight: ≈159.21 Da (as cation)
• CAS Number: Not universally standardized (research compound; often referenced in NNMT inhibitor literature)
• Form: White to off-white lyophilized powder
• Storage: –20 °C long-term; 2–8 °C after reconstitution with bacteriostatic water or PBS
• COA: Batch-specific analytical report included

In research, 5-Amino-1MQ 10mg Peptide inhibits NNMT, preventing the methylation of nicotinamide (a NAD+ precursor) into 1-methylnicotinamide. This preserves NAD+ availability, boosts sirtuin activity, enhances mitochondrial function, and shifts metabolism toward fat oxidation.

Here are professional examples of 5-Amino-1MQ 10mg Peptide research-grade lyophilized vials in sterile glass packaging, illustrating the clean, high-quality presentation typical for lab use:

How Does 5-Amino-1MQ 10mg Peptide Work in Biological Systems?

5-Amino-1MQ 10mg Peptide selectively binds and inhibits NNMT, an enzyme highly expressed in adipose tissue, liver, and other metabolic organs. NNMT catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide, producing 1-methylnicotinamide and depleting the NAD+ salvage pathway precursor pool.

By blocking this reaction, 5-Amino-1MQ 10mg Peptide:

• Preserves nicotinamide for NAD+ resynthesis via salvage pathways
• Elevates intracellular NAD+ levels
• Activates NAD+-dependent sirtuins (SIRT1, SIRT3) for metabolic regulation
• Enhances mitochondrial fatty acid oxidation and energy expenditure
• Reduces white adipose tissue accumulation and adipocyte size
• Improves insulin sensitivity and glucose handling in models

These effects are concentration-dependent and often fit sigmoidal dose-response curves in adipocyte and animal studies.

Research Applications of 5-Amino-1MQ 10mg Peptide

5-Amino-1MQ 10mg Peptide is applied in:

• Obesity and metabolic syndrome models (DIO, high-fat diet reversal)
• NAD+ metabolism and sirtuin activation studies
• Fat oxidation and mitochondrial bioenergetics (indirect calorimetry, Seahorse)
• Adipocyte differentiation and lipolysis assays
• Liver steatosis (NAFLD) and insulin resistance analogs
• Aging-related metabolic decline and frailty research

Key endpoints where 5-Amino-1MQ 10mg Peptide excels:

• Reduction in body weight and adipose mass
• Restoration of NAD+/NADH ratio (LC-MS/MS)
• Increased oxygen consumption and energy expenditure
• Improved insulin sensitivity (glucose tolerance tests)
• Decreased NNMT activity and 1-methylnicotinamide levels
• Enhanced mitochondrial function and reduced ROS

Usage and Reconstitution Guidelines for 5-Amino-1MQ 10mg Peptide

1. Allow vial to reach room temperature.
2. Add 1–2 mL bacteriostatic water or sterile PBS; gently swirl to dissolve.
3. Prepare stock solutions (e.g., 5 mg/mL) and dilute for working concentrations (typically 1–100 μM in vitro or 10–50 mg/kg in vivo).
4. Aliquot immediately and store at –80 °C; thawed aliquots stable 2–8 °C for days.

Common routes: oral gavage (high bioavailability in models), intraperitoneal, or direct addition to cell culture media.

Frequently Asked Questions About 5-Amino-1MQ 10mg Peptide

Q: How does 5-Amino-1MQ 10mg Peptide differ from NAD+ precursors like NMN or NR? A: It directly inhibits NNMT to preserve endogenous nicotinamide for NAD+ salvage, often achieving more efficient NAD+ elevation in adipose/liver tissues than precursors alone.

Q: What dosing ranges are common in preclinical literature? A: In-vivo studies often use 10–50 mg/kg (oral or IP); in-vitro concentrations typically 1–100 μM in adipocytes or hepatocytes.

Q: Is 5-Amino-1MQ 10mg Peptide cell-permeable? A: Yes—studies show excellent membrane permeability and intracellular NNMT inhibition in adipocytes.

Q: Suitable for muscle or mitochondrial studies? A: Yes—emerging data link NNMT inhibition to improved muscle NAD+ and strength in aging models.

Q: Stability post-reconstitution? A: Stable for weeks refrigerated when aliquoted; freeze for longer storage.

Q: How to verify batch quality? A: Cross-reference the provided COA on the product page.

What Metabolic Puzzle Could 5-Amino-1MQ 10mg Peptide Help You Solve?

With NNMT emerging as a key driver of metabolic inefficiency, what specific fat oxidation pathway, NAD+ preservation mechanism, or obesity-related resistance might 5-Amino-1MQ 10mg Peptide illuminate in your models? Could it redefine how you approach adipose tissue reprogramming or insulin sensitivity research?

Share your research angle—the scientific dialogue drives discovery.

In summary, 5-Amino-1MQ 10mg Peptide from Cali BioLab Peptides is a selective NNMT inhibitor with compelling potential in metabolic and longevity studies. With superior purity, reliable supply, and growing preclinical evidence, it's ready to support your 2026 investigations into fat metabolism and NAD+ biology.

Order your 5-Amino-1MQ 10mg Peptide today at Cali BioLab Peptides and target NNMT with precision in your experiments.